DDICX
Price
$16.09
Change
+$0.06 (+0.37%)
Updated
Oct 17 closing price
Net Assets
836.81M
RLEFX
Price
$38.98
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

DDICX vs RLEFX

Header iconDDICX vs RLEFX Comparison
Open Charts DDICX vs RLEFXBanner chart's image
Macquarie Wealth Builder C
Price$16.09
Change+$0.06 (+0.37%)
VolumeN/A
Net Assets836.81M
American Funds American Balanced R5E
Price$38.98
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
DDICX vs RLEFX Comparison Chart in %
View a ticker or compare two or three
VS
DDICX vs. RLEFX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDICX is a Hold and RLEFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 265B vs. DDICX (837M). RLEFX pays higher dividends than DDICX: RLEFX (1.92) vs DDICX (0.82). DDICX was incepted earlier than RLEFX: DDICX (22 years) vs RLEFX (10 years). DDICX (1.84) is less costly to investors than RLEFX (0.39). DDICX is a more actively managed with annual turnover of: 66.00 vs. RLEFX (44.00). RLEFX has a lower initial minimum investment than DDICX: RLEFX (250) vs DDICX (1000). RLEFX annual gain was more profitable for investors over the last year : 8.94 vs. DDICX (2.64). RLEFX return over 5 years is better than : 43.26 vs. DDICX (27.49).
DDICXRLEFXDDICX / RLEFX
Total Expense Ratio1.810.39464%
Annual Report Gross Expense Ratio1.840.39472%
Fund Existence22 years10 years-
Gain YTD9.73314.81966%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets837M265B0%
Annual Yield % from dividends0.821.9243%
Returns for 1 year2.648.9430%
Returns for 3 years24.5451.3948%
Returns for 5 years27.4943.2664%
Returns for 10 years34.41N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COEP15.380.38
+2.53%
Coeptis Therapeutics Holdings Inc
STC69.760.91
+1.32%
Stewart Information Services Corp
ATMVU22.00N/A
N/A
AlphaVest Acquisition Corp
BBIO54.92-0.11
-0.20%
BridgeBio Pharma
SRTA4.99-0.09
-1.77%
Strata Critical Medical Inc